Recursion Pharmaceuticals, Inc. RXRX

Set alert

3.88 USD +0.20 (+5.43%)

At closeNov 4, 2026, 7:56 PM EST

3.85 -0.03 -0.77%

After hours · Nov 4, 7:56 PM ET

3.72 Day range 4.01

2.84 52-week range 5.00

Held by insiders 1.75%

Held by institutions 61.55%

Float held by institutions 62.64%

Institutions 445

Top institutional holders
Holder	% held	Shares	Value	Reported
Blackrock Inc.	8.08%	50,304,691	195.18M	Jun 29, 2026
ARK Investment Management, LLC	6.64%	41,337,632	160.39M	Jun 29, 2026
State Street Corporation	5.57%	34,706,130	134.66M	Jun 29, 2026
Vanguard Portfolio Management LLC	5.00%	31,131,599	120.79M	Jun 29, 2026
BAILLIE GIFFORD & CO	3.77%	23,487,907	91.13M	Jun 29, 2026
Vanguard Capital Management LLC	3.66%	22,765,940	88.33M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
ARK ETF Trust-ARK Innovation ETF	3.81%	23,715,619	92.02M	Sep 29, 2026
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF	2.67%	16,610,690	64.45M	Sep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	2.54%	15,819,431	61.38M	Jun 29, 2026
ARK ETF Trust-ARK Genomic Revolution ETF	2.25%	14,027,607	54.43M	Sep 29, 2026
iShares Trust-iShares Russell 2000 ETF	2.14%	13,319,007	51.68M	Sep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund	1.83%	11,420,983	44.31M	Jun 29, 2026

RXRX insiders
Insider	Relation	Latest transaction	Date	Shares held
BORGESON BLAKE CHARLES	Director	Sale	Oct 5, 2026	6,108,290
DAR ZAVAIN	Director	Stock Award(Grant)	Jun 30, 2026	240,764
GIBSON CHRISTOPHER C.	Director	Sale	Jun 4, 2026	883,735
HALLETT DAVID	Officer	Stock Award(Grant)	Feb 5, 2026	1,109,060
HERSHBERG ROBERT M	Director	Sale	Oct 5, 2026	162,156
KHAN NAJAT	Chief Executive Officer	Sale	Sep 7, 2026	2,072,890

Held by funds